Report Detail
Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Research Report 2020, Forecast to 2025
- RnM4236866 |
- 28 October, 2020 |
- Global |
- 164 Pages |
- Multimarket Insight |
- Medical Devices & Consumables
The report forecast global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market to grow to reach xx Million USD in 2020 with a CAGR of xx% during the period of 2020-2025. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue. Estimates of the regional markets for Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment are based on the applications market.
The report demonstrates detail coverage of Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment industry and main market trends.
The market research includes historical and forecast data, like demand, application details, price trends, and company shares of the leading Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Since the COVID-19 virus outbreak in December 2019, the World Health Organization declared it a public health emergency. The desease has spread to over 100 countries and caused huge losses of lives around the globe. Especially the global manufacturing, tourism and financial markets have been hit hard. The downward pressure on the world economy that once showed signs of recovery in the previous period has increased again. The outbreak of the epidemic has added risk factors to the already weak growth of the world economy. Many international organizations have pointed out that the world economy is in the most severe period since the financial crisis.
The negative global impacts of the coronavirus are already there, significantly affecting the Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market in 2020. This report studies and analyzes the in-depth impact of Coronavirus COVID-19 on the Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment industry.
In addition, the report provides insight into main drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market are discussed. And this report covers the historical situation, present status and the future prospects of the global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market for 2015-2025.
Market Segment by Product Type
Pcr
In Situ Hybridization
Chips And Microarrays
Isothermal Nucleic Acid Amplification Technology (Inaat)
Mass Spectrometry
Sequencing
Transcription Mediated Amplification
Market Segment by Product Application
Hospital
Research
Clinic
Finally, the report provides detailed profile and data information analysis of leading company.
Cepheid
Beckton Dickinson
Gen Probe (Hologic)
Qiagen
Roche
Bayer Healthcare
Dako
Abbott Laboratories
Danaher
Siemens
Sysmex
Grifols
Biomérieux
Report Includes:
- xx data tables (appendix tables)
- Overview of global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market
- Profiles of major players in the industry, including Cepheid, Beckton Dickinson, Gen Probe (Hologic), Qiagen, Roche.....
Research Objectives
1.To study and analyze the global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
2.To understand the structure of Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market by identifying its various subsegments.
3.Focuses on the key global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Research Report 2020, Forecast to 2025
1 Market Overview
- 1.1 Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Definition
- 1.1.1 Analysis of Macroeconomic Indicators
- 1.1.2 Years Considered
- 1.2 Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Segment by Type
- 1.2.1 Pcr
- 1.2.2 In Situ Hybridization
- 1.2.3 Chips And Microarrays
- 1.2.4 Isothermal Nucleic Acid Amplification Technology (Inaat)
- 1.2.5 Mass Spectrometry
- 1.2.6 Sequencing
- 1.2.7 Transcription Mediated Amplification
- 1.3 Market Analysis by Application
- 1.3.1 Hospital
- 1.3.2 Research
- 1.3.3 Clinic
- 1.4 Overview of Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market
- 1.4.1 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue (2015-2025)
- 1.4.2 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production and Capacity (2015-2025)
- 1.4.3 North America Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Status and Prospect (2015-2025)
- 1.4.4 Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Status and Prospect (2015-2025)
- 1.4.5 Japan Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Status and Prospect (2014-2025)
- 1.4.6 China Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Status and Prospect (2015-2025)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
- 1.5.4 Porter's Five Forces Analysis
- 1.5.5 SWOT Analysis
- 1.6 Coronavirus Disease 2019 (Covid-19): Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Industry
- 1.6.2 Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Business Impact Assessment - Covid-19
- 1.6.3 Market Trends and Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Potential Opportunities in the COVID-19 Landscape
- 1.6.4 Measures / Proposal against Covid-19
2 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Competition by Manufacturer
- 2.1 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales and Market Share by Manufacturer (2018-2020)
- 2.2 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue and Market Share by Manufacturer (2018-2020)
- 2.3 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Industry Concentration Ratio (CR5 and HHI)
- 2.4 Top 5 Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturer Market Share
- 2.5 Top 10 Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturer Market Share
- 2.6 Date of Key Manufacturers Enter into Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market
- 2.7 Key Manufacturers Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Product Offered
- 2.8 Mergers & Acquisitions Planning
3 Analysis of Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Industry Key Manufacturers
- 3.1 Cepheid
- 3.1.1 Company Details
- 3.1.2 Product Information
- 3.1.3 Cepheid Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
- 3.1.4 Main Business Overview
- 3.1.5 Cepheid News
- 3.2 Beckton Dickinson
- 3.2.1 Company Details
- 3.2.2 Product Information
- 3.2.3 Beckton Dickinson Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
- 3.2.4 Main Business Overview
- 3.2.5 Beckton Dickinson News
- 3.3 Gen Probe (Hologic)
- 3.3.1 Company Details
- 3.3.2 Product Information
- 3.3.3 Gen Probe (Hologic) Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
- 3.3.4 Main Business Overview
- 3.3.5 Gen Probe (Hologic) News
- 3.4 Qiagen
- 3.4.1 Company Details
- 3.4.2 Product Information
- 3.4.3 Qiagen Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
- 3.4.4 Main Business Overview
- 3.4.5 Qiagen News
- 3.5 Roche
- 3.5.1 Company Details
- 3.5.2 Product Information
- 3.5.3 Roche Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
- 3.5.4 Main Business Overview
- 3.5.5 Roche News
- 3.6 Bayer Healthcare
- 3.6.1 Company Details
- 3.6.2 Product Information
- 3.6.3 Bayer Healthcare Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
- 3.6.4 Main Business Overview
- 3.6.5 Bayer Healthcare News
- 3.7 Dako
- 3.7.1 Company Details
- 3.7.2 Product Information
- 3.7.3 Dako Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
- 3.7.4 Main Business Overview
- 3.7.5 Dako News
- 3.8 Abbott Laboratories
- 3.8.1 Company Details
- 3.8.2 Product Information
- 3.8.3 Abbott Laboratories Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
- 3.8.4 Main Business Overview
- 3.8.5 Abbott Laboratories News
- 3.9 Danaher
- 3.9.1 Company Details
- 3.9.2 Product Information
- 3.9.3 Danaher Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
- 3.9.4 Main Business Overview
- 3.9.5 Danaher News
- 3.10 Siemens
- 3.10.1 Company Details
- 3.10.2 Product Information
- 3.10.3 Siemens Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
- 3.10.4 Main Business Overview
- 3.10.5 Siemens News
- 3.11 Sysmex
- 3.11.1 Company Details
- 3.11.2 Product Information
- 3.11.3 Sysmex Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
- 3.11.4 Main Business Overview
- 3.11.5 Sysmex News
- 3.12 Grifols
- 3.12.1 Company Details
- 3.12.2 Product Information
- 3.12.3 Grifols Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
- 3.12.4 Main Business Overview
- 3.12.5 Grifols News
- 3.13 Biomérieux
- 3.13.1 Company Details
- 3.13.2 Product Information
- 3.13.3 Biomérieux Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
- 3.13.4 Main Business Overview
- 3.13.5 Biomérieux News
4 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Size Categorized by Regions (2015-2020)
- 4.1 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Region
- 4.2 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue Market Share by Region (2015-2019)
- 4.3 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2015-2020)
- 4.4 North America Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Size Detail
- 4.4.1 North America Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Growth Rate (2015-2020)
- 4.4.2 North America Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2015-2020)
- 4.5 Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Size Detail
- 4.5.1 Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Growth Rate (2015-2020)
- 4.5.2 Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2015-2020)
- 4.6 Japan Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Size Detail
- 4.6.1 Japan Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Growth Rate (2015-2020)
- 4.6.2 Japan Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2015-2020)
- 4.7 China Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Size Detail
- 4.7.1 China Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Growth Rate (2015-2020)
- 4.7.2 China Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2015-2020)
5 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Segment by Type
- 5.1 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue, Sales and Market Share by Type (2015-2020)
- 5.1.1 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales and Market Share by Type (2015-2020)
- 5.1.2 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue and Market Share by Type (2015-2020)
- 5.2 Pcr Sales Growth Rate and Price
- 5.2.1 Global Pcr Sales Growth Rate (2015-2020)
- 5.2.2 Global Pcr Price (2015-2020)
- 5.3 In Situ Hybridization Sales Growth Rate and Price
- 5.3.1 Global In Situ Hybridization Sales Growth Rate (2015-2020)
- 5.3.2 Global In Situ Hybridization Price (2015-2020)
- 5.4 Chips And Microarrays Sales Growth Rate and Price
- 5.4.1 Global Chips And Microarrays Sales Growth Rate (2015-2020)
- 5.4.2 Global Chips And Microarrays Price (2015-2020)
- 5.5 Isothermal Nucleic Acid Amplification Technology (Inaat) Sales Growth Rate and Price
- 5.5.1 Global Isothermal Nucleic Acid Amplification Technology (Inaat) Sales Growth Rate (2015-2020)
- 5.5.2 Global Isothermal Nucleic Acid Amplification Technology (Inaat) Price (2015-2020)
- 5.6 Mass Spectrometry Sales Growth Rate and Price
- 5.6.1 Global Mass Spectrometry Sales Growth Rate (2015-2020)
- 5.6.2 Global Mass Spectrometry Price (2015-2020)
- 5.7 Sequencing Sales Growth Rate and Price
- 5.7.1 Global Sequencing Sales Growth Rate (2015-2020)
- 5.7.2 Global Sequencing Price (2015-2020)
- 5.8 Transcription Mediated Amplification Sales Growth Rate and Price
- 5.8.1 Global Transcription Mediated Amplification Sales Growth Rate (2015-2020)
- 5.8.2 Global Transcription Mediated Amplification Price (2015-2020)
6 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Segment by Application
- 6.1 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Market Share by Application (2015-2020)
- 6.2 Hospital Sales Growth Rate (2015-2020)
- 6.3 Research Sales Growth Rate (2015-2020)
- 6.4 Clinic Sales Growth Rate (2015-2020)
7 Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Related Market Analysis
- 7.1 Upstream Analysis
- 7.1.1 Macro Analysis of Upstream Markets
- 7.1.2 Key Players in Upstream Markets
- 7.1.3 Upstream Market Trend Analysis
- 7.1.4 Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturing Cost Analysis
- 7.2 Downstream Market Analysis
- 7.2.1 Macro Analysis of Down Markets
- 7.2.2 Key Players in Down Markets
- 7.2.3 Downstream Market Trend Analysis
- 7.2.4 Sales Channel, Distributors, Traders and Dealers
8 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Forecast
- 8.1 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales, Revenue Forecast
- 8.1.1 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Growth Rate Forecast (2020-2025)
- 8.1.2 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Revenue and Growth Rate Forecast (2020-2025)
- 8.1.3 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Price and Trend Forecast (2020-2025)
- 8.2 Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales Forecast by Region (2020-2025)
- 8.2.1 North America Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales, Revenue Forecast (2020-2025)
- 8.2.2 Europe Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Sales, Revenue Forecast (2020-2025)
- 8.2.3 Japan Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Revenue Forecast (2020-2025)
- 8.2.4 China Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Production, Revenue Forecast (2020-2025)
9 Research Findings and Conclusion
10 Appendix
Summary:
Get latest Market Research Reports on Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment. Industry analysis & Market Report on Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment is a syndicated market report, published as Global Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market Research Report 2020, Forecast to 2025. It is complete Research Study and Industry Analysis of Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
